Discover 1,112 paid clinical trials in Hartford, Connecticut. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,112
Genetic Analysis of Keloids
for
Keloid
Location: Farmington CT
Sponsor: UConn Health
Sex: All
Age: 0+
Code: NCT01619553
Recruiting
Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)
for
Idiopathic Pulmonary Fibrosis
Location: Farmington CT, New York NY, Philadelphia PA,
Sponsor: Cumberland Pharmaceuticals
Sex: All
Age: 40+
Code: NCT05571059
Phase 2, Recruiting
A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
for
Relapsed or Refractory Multiple Myeloma
Location: Farmington CT, Shirley NY, Lake Success NY, Boston MA,
Sponsor: Celgene
Sex: All
Age: 18+
Code: NCT05519085
Phase 3, Recruiting
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)
for
Psychosis Associated With Alzheimer's Disease
Location: Farmington CT, Woodmere NY, Matthews NC, Atlanta GA,
Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Sex: All
Age: 55 - 70+
Code: NCT05980949
Phase 3, Recruiting
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
for
Depressive Disorder, Major
Location: Farmington CT, Mount Kisco NY, Watertown MA,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18 - 70+
Code: NCT06559306
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Beta-blocker Discontinuation in Heart Failure With Preserved Ejection Fraction
for
Heart Failure With Preserved Ejection Fraction
Location: Farmington CT
Sponsor: UConn Health
Sex: All
Age: 50 - 70+
Code: NCT05174351
Recruiting
Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation
Location: Farmington CT, Shelby MI, Indianapolis IN, Hinsdale IL,
Sponsor: Biohaven Therapeutics Ltd.
Sex: All
Age: 18 - 65
Code: NCT07054684
Phase 1, Recruiting
A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
for
Parkinson Disease
Location: Farmington CT, New Haven CT, Foxborough MA, Albany NY,
Sponsor: Biohaven Therapeutics Ltd.
Sex: All
Age: 40 - 70+
Code: NCT06976268
Phase 2, Phase 3, Recruiting
Study to Evaluate the Safety of CG-P5 Peptide Eye Drops in Patients Diagnosed With Age-related Wet Macular Degeneration
for
Age-related Wet Macular Degeneration
Location: Manchester CT, Philadelphia PA, Erie PA, Carmel IN,
Sponsor: Caregen Co. Ltd.
Sex: All
Age: 50+
Code: NCT06132035
Phase 1, Recruiting
Intravitreal Faricimab Injections or Fluocinolone Acetonide (0.19 mg) Intravitreal Implants vs Observation for Prevention of VA Loss Due to Radiation Retinopathy
for
Radiation Retinopathy, Visual Impairment
Location: Manchester CT, Boston MA, Philadelphia PA,
Sponsor: Jaeb Center for Health Research
Sex: All
Age: 18+
Code: NCT05844982
Phase 3, Recruiting
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PEAK
for
Macular Edema Secondary to Inflammation
Location: Manchester CT, Waterford CT, Greenwich CT, Boston MA,
Sponsor: Kodiak Sciences Inc
Sex: All
Age: 18+
Code: NCT06990399
Phase 3, Recruiting
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLE
for
Macular Edema Secondary to Inflammation
Location: Manchester CT, Waterford CT, Greenwich CT, Boston MA,
Sponsor: Kodiak Sciences Inc
Sex: All
Age: 18+
Code: NCT06996080
Phase 3, Recruiting
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy